# Neurocrine Biosciences (United States)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/neurocrine-biosciences-united-states/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 27 |
| Citations | 192,127 |
| City | San Diego |
| Country | US |
| Description | Neurocrine Biosciences (United States) is a research organisation in San Diego, US. OpenAlex records 1,274 works and 192,127 citations for it. 400 researchers list it as their most recent affiliation. |
| Homepage | http://www.neurocrine.com/ |
| OpenAlex ID | https://openalex.org/I67391869 |
| Researchers | 400 |
| ROR ID | https://ror.org/05d84mm26 |
| Type | company |
| Wikidata ID | https://www.wikidata.org/wiki/Q7002174 |
| Works | 1,274 |

## University papers

Showing 12 of 21.

- [A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression](https://scholariq.org/papers/a-randomized-trial-of-an-n-methyl-d-aspartate-antagonist-in-treatment-resistant/)
- [Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study](https://scholariq.org/papers/efficacy-and-safety-of-flexibly-dosed-esketamine-nasal-spray-combined-with-a/)
- [Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression](https://scholariq.org/papers/efficacy-of-esketamine-nasal-spray-plus-oral-antidepressant-treatment-for/)
- [Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression](https://scholariq.org/papers/efficacy-and-safety-of-intranasal-esketamine-adjunctive-to-oral-antidepressant/)
- [Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study](https://scholariq.org/papers/efficacy-and-safety-of-intranasal-esketamine-for-the-rapid-reduction-of-symptoms/)
- [Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)](https://scholariq.org/papers/efficacy-and-safety-of-fixed-dose-esketamine-nasal-spray-combined-with-a-new/)
- [A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression](https://scholariq.org/papers/a-double-blind-randomized-placebo-controlled-dose-frequency-study-of-intravenous/)
- [Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression—TRANSFORM-3](https://scholariq.org/papers/efficacy-and-safety-of-esketamine-nasal-spray-plus-an-oral-antidepressant-in/)
- [Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study](https://scholariq.org/papers/intravenous-esketamine-in-adult-treatment-resistant-depression-a-double-blind/)
- [A Double-Blind, Placebo-Controlled Study of Memantine in the Treatment of Major Depression](https://scholariq.org/papers/a-double-blind-placebo-controlled-study-of-memantine-in-the-treatment-of-major/)
- [The impact of urinary incontinence on quality of life of the elderly.](https://scholariq.org/papers/the-impact-of-urinary-incontinence-on-quality-of-life-of-the-elderly/)
- [Prevalence of narcolepsy and other sleep disorders and frequency of diagnostic tests from 2013–2016 in insured patients actively seeking care](https://scholariq.org/papers/prevalence-of-narcolepsy-and-other-sleep-disorders-and-frequency-of-diagnostic/)

## University researchers

- [Jaskaran Singh](https://scholariq.org/researchers/jaskaran-singh/)
- [Morgan Bron](https://scholariq.org/researchers/morgan-bron/)

## University top topics

Showing 8 of 25.

- [Stress Responses and Cortisol](https://scholariq.org/topics/stress-responses-and-cortisol/)
- [Receptor Mechanisms and Signaling](https://scholariq.org/topics/receptor-mechanisms-and-signaling/)
- [Adrenal Hormones and Disorders](https://scholariq.org/topics/adrenal-hormones-and-disorders/)
- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Hormonal Regulation and Hypertension](https://scholariq.org/topics/hormonal-regulation-and-hypertension/)
- [Neuroscience and Neuropharmacology Research](https://scholariq.org/topics/neuroscience-and-neuropharmacology-research/)
- [Regulation of Appetite and Obesity](https://scholariq.org/topics/regulation-of-appetite-and-obesity/)
- [Biochemical Analysis and Sensing Techniques](https://scholariq.org/topics/biochemical-analysis-and-sensing-techniques/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.